摘要
目的了解武汉地区2014-2016年抗病毒药的使用情况,分析其变化趋势。方法采用限定日剂量法对2014-2016年武汉地区31家医院抗病毒药的销售金额、用药频度(DDDs)和日均费用(DDC)进行统计分析。结果2014-2016年抗病毒药销售总金额无显著性变化,销售排名前3为分别为恩替卡韦、聚乙二醇干扰素α-2a及阿德福韦酯。2015年用药频度较2014年降低26. 92%,与2016年基本持平。利巴韦林的日均费用较低,且逐年下降,至2016年为1. 30元/d。结论武汉地区抗病毒药用药结构较为合理、稳定,恩替卡韦和阿德福韦酯最为临床认可。
Objective To understand the use of antiviral drugs in the area of Wuhan from 2014 to 2016 and analyze their trends. Methods Using the defined daily dose method to analyse the amount of sales,DDDs and DDD of antiviral drugs of 31 hospitals in Wuhan area from 2014 to 2016. Results From 2014 to 2016 the total amount of antiviral sales in Wuhan no significant change,sales top 3 of were entecavir,peginterferα-2a and adefovir. DDDs in 2015 decreased by 26. 92% than in 2014,and the same as in 2016. Daily cost of ribavirin was low and decreased year by year,it's 1. 30 yuan/d in 2016. Conclusion The use of antiviral drugs in Wuhan is reasonable and stable. Entecavir and adefovir are most recognized in clinical.
作者
王璐
WANG Lu(Department of Pharmacy,Tongji Hospital Affili-ated with Tongji Medical College Huazhong University of Science and Technology,Hubei Province,Wuhan 430030,China)
出处
《临床合理用药杂志》
2018年第34期1-3,共3页
Chinese Journal of Clinical Rational Drug Use
关键词
抗病毒药
限定日剂量
用药频度
日均费用
用药分析
Antiviral drugs
Defined Daily Dose
DDDs
Daily Drug Cost
Analysis of drug use
